Table 2 Voiding methods and bladder medication in participants across time-interval subgroups.
Variables | Complete | Value (p) | Incomplete | Value (p) | ||||
|---|---|---|---|---|---|---|---|---|
0â90 N (%) | 90â135 N (%) | 135â180 N (%) | 0â90 N (%) | 90â135 N (%) | 135â180 N (%) | |||
Voiding method | Â | Â | Â | 7.933b (0.380) | Â | Â | Â | 6.035b (0.631) |
âFoley | 6 (54.5) | 13 (39.4) | 3 (15.8) | 10 (29.4) | 11 (18.0) | 4 (12.1) | ||
âSuprapubic | 0 (0.0) | 1 (3.0) | 0 (0.0) | 1 (2.9) | 1 (1.6) | 0 (0.0) | ||
âCIC | 5 (45.5) | 16 (48.5) | 12 (63.2) | 8 (23.5) | 17 (27.9) | 9 (27.3) | ||
âSpontaneous voiding | 0 (0.0) | 2 (6.1) | 2 (10.5) | 14 (41.2) | 30 (49.2) | 20 (60.6) | ||
âCombined methodsc | 0 (0.0) | 1 (3.0) | 2 (10.5) | 1 (2.9) | 2 (3.3) | 0 (0.0) | ||
Bladder medication | Â | Â | Â | 1.487b (0.846) | Â | Â | Â | 7.649a (0.105) |
âNot used | 7 (63.6) | 18 (54.5) | 13 (68.4) | 26 (76.5) | 32 (52.5) | 17 (51.5) | ||
â1 used | 2 (18.2) | 10 (30.3) | 4 (21.1) | 7 (20.6) | 17 (27.9) | 10 (30.3) | ||
â2 Used | 2 (18.2) | 5 (15.2) | 2 (10.5) | 1 (2.9) | 12 (19.7) | 6 (18.2) | ||